Showing results (51-60 of 129) with videos related to
Sort By:
Pageof 13
Diabetes Care|August 24, 2014
Sulfonylurea use and incident cardiovascular disease among patients with type 2 diabetes: prospective cohort study among womenYanping Li, Yang Hu, Sylvia H Ley, et al.Diabetes Care|May 30, 2006
Iron intake and the risk of type 2 diabetes in women: a prospective cohort studySwapnil Rajpathak, Jing Ma, JoAnn Manson, et al.Diabetes & Metabolic Syndrome|January 16, 2019
Chronic kidney disease among US adults with type 2 diabetes and cardiovascular diseases: A national estimate of prevalence by KDIGO 2012 classificationTongtong Wang, Yuzhi Xi, Robert Lubwama, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|November 11, 2022
Global epidemiology of factor XI deficiency: A targeted review of the literature and foundation reportsXinruo Zhang, Magdalena Lewandowska, Molly Aldridge, et al.The American Journal of Managed Care|May 24, 2019
Cost-effectiveness of DPP-4 inhibitor and SGLT2 inhibitor combination therapy for type 2 diabetesManjiri Pawaskar, S Pinar Bilir, Stacey Kowal, et al.Journal of Diabetes and Its Complications|August 28, 2014
Risk characterization for urinary tract infections in subjects with newly diagnosed type 2 diabetesAlex Z Fu, Kristy Iglay, Ying Qiu, et al.Diabetes Research and Clinical Practice|May 2, 2021
Comorbidities and complications in Japanese patients with type 2 diabetes mellitus: Retrospective analyses of J-DREAMS, an advanced electronic medical records databaseMitsuru Ohsugi, Jun-Ichi Eiki, Kristy Iglay, et al.Diabetes, Obesity & Metabolism|December 20, 2018
Cost-effectiveness of intensification with sodium-glucose co-transporter-2 inhibitors in patients with type 2 diabetes on metformin and sitagliptin vs direct intensification with insulin in the United KingdomManjiri Pawaskar, S Pinar Bilir, Stacey Kowal, et al.Endocrinology, Diabetes & Metabolism|March 1, 2019
Severity of hypoglycaemia and health-related quality of life, work productivity and healthcare costs in patients with type 2 diabetes in EuropeManjiri Pawaskar, Edward A Witt, Samuel S Engel, et al.Expert Review of Pharmacoeconomics & Outcomes Research|August 23, 2018
Factors associated with physicians' decision to discontinue or down-titrate sulfonylureas for type 2 diabetes patientsPedro Laires, Karen Kurtyka, Edward A Witt, et al.Pageof 13